Haigh Adrian 4
4 · FENNEC PHARMACEUTICALS INC. · Filed May 21, 2024
Insider Transaction Report
Form 4
Haigh Adrian
Director
Transactions
- Award
Restricted Shste Unit
2024-05-16+25,000→ 435,246 totalExercise: $0.00From: 2025-05-16Exp: 2034-05-16→ Common Shares (25,000 underlying) - Award
Stock Option
2024-05-16+50,000→ 410,246 totalExercise: $7.12From: 2025-05-16Exp: 2034-05-16→ Common Shares (50,000 underlying)
Footnotes (4)
- [F1]On May 16, 2024, Adrian Haigh was granted incentive stock options to purchase 50,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan.
- [F2]2. One-third of the shares subject to this option may be exercised as of May 16, 2025 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this option may be exercised as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027 and thereafter, 100% of the total number of shares subject to this option shall be vested.
- [F3]On May 16, 2024, Adrina Haigh was awarded restricted share units to acquire 25,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan
- [F4]One-third of the shares subject to this award shall be released from restriction as of May 16, 2025 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction..